Evidence map›Paper›PMID 25395848›Full record

ArticleInternational journal of nanomedicine2014

Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging.

Zhong Cao, Wenjian Zhu, Wei Wang, Chunyang Zhang, Ming Xu, Jie Liu, Shi-Ting Feng, Qing Jiang, Xiaoyan Xie

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Advancing the Pharmaceutical Potential of Bioinorganic Hybrid Lipid-Based Assemblies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2018
    Review
  5. Article
  6. Review
  7. Review
  8. A Conjugate of Pentamethine Cyanine andInternational journal of molecular sciences · 2017
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhong CaoDepartment of Biomedical Engineering, College of Engineering, Guangzhou, People's Republic of China.
Wenjian ZhuDepartment of Biomedical Engineering, College of Engineering, Guangzhou, People's Republic of China.
Wei WangDepartment of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-sen University, Institute of Diagnostic and Interventional Ultrasound, Guangzhou, People's Republic of China.
Chunyang ZhangDepartment of Biomedical Engineering, College of Engineering, Guangzhou, People's Republic of China.
Ming XuDepartment of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-sen University, Institute of Diagnostic and Interventional Ultrasound, Guangzhou, People's Republic of China.
Jie LiuDepartment of Biomedical Engineering, College of Engineering, Guangzhou, People's Republic of China.
Shi-Ting FengDepartment of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Qing JiangDepartment of Biomedical Engineering, College of Engineering, Guangzhou, People's Republic of China.
Xiaoyan XieDepartment of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-sen University, Institute of Diagnostic and Interventional Ultrasound, Guangzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic liposomes have been frequently used as nanocarriers for targeted drug delivery and magnetic resonance imaging in recent years. Despite great potentials, their morphological/structural instability in the physiological environment still remains an intractable challenge for clinical applications. In this study, stable hybrid liposomal cerasomes (ie, liposomes partially coated with silica) which can co-encapsulate Fe3O4 nanoparticles and the anticancer drug paclitaxel were developed using thin film hydration method. Compared with the drug loaded liposomes, the paclitaxel-loaded magnetic cerasomes (PLMCs) exhibited much higher storage stability and better sustained release behavior. Cellular uptake study showed that the utilization of an external magnetic field significantly facilitated the internalization of PLMCs into cancer cells, resulting in potentiated drug efficacy of killing tumor cells. The T2 relaxivity (r2) of our PLMCs was much higher than that of free Fe3O4 nanoparticles, suggesting increased sensitivity in T2-weighted imaging. Given its excellent biocompatibility also shown in the study, such dual functional PLMC is potentially a promising nanosystem for effective cancer diagnosis and therapy.

Indexed as

Antineoplastic AgentsCell SurvivalDrug Delivery SystemsErythrocytesHeLa CellsHemolysisHumansLiposomesMagnetic Resonance ImagingMagnetite NanoparticlesPaclitaxelSilicon DioxideAntineoplastic AgentsLiposomesMagnetite NanoparticlesPaclitaxelSilicon DioxideMRIpaclitaxelSPIOsuperparamagnetic iron oxide

Identifiers

PMID25395848
PMCPMC4227624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.